Short- and Long-Term Risk Stratification in Acute Coronary Syndromes

This publication has 30 references indexed in Scilit:

• A Validated Prediction Model for All Forms of Acute Coronary Syndrome
  JAMA, 2004
• Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients
  Journal of the American College of Cardiology, 2003
• Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina
  Circulation, 2003
• Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb
  Journal of the American College of Cardiology, 2001
• Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
  The Lancet, 2001
• The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
  JAMA, 2000
• Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation
  Circulation, 2000
• Very Early Risk Stratification Using Combined ECG and Biochemical Assessment in Patients With Unstable Coronary Artery Disease (A Thrombin Inhibition in Myocardial Ischemia [TRIM] Substudy)
  Circulation, 1998
• Acute Coronary Syndromes in the GUSTO-IIb Trial
  Circulation, 1998
• The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.
  Journal of the American College of Cardiology, 1997